AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 172 GBX
-0.6%
Market Closed
Updated:
May 15, 2024
AstraZeneca PLC
Net Change in Cash
|
AstraZeneca PLC
Net Change in Cash Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Net Change in Cash
$1.9B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Net Change in Cash
-£133m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Net Change in Cash
$43.9m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Net Change in Cash
-$340m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Net Change in Cash
-$65m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-22%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Net Change in Cash
-£46.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AstraZeneca PLC's Net Change in Cash?
Net Change in Cash
1.9B
USD
1.9B
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Net Change in Cash amounts to 1.9B USD.
What is AstraZeneca PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
8%
8%
Over the last year, the Net Change in Cash growth was 292%. The average annual Net Change in Cash growth rates for AstraZeneca PLC have been -24% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
